NCT03170050

Clinical Trial of YYD701-2 for Treatment of Nasolabial Folds

A Multicenter, Active-controlled, Randomized, Evaluator and Subject Blinded, Split-face, Comparative, Non-inferiority and Confirmatory Clinical Study of the Efficacy and Safety Between YYD701-2 and Restylane Perlane Lidocaine for Temporary Correction of Moderate to Severe Nasolabial Folds

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 107 (actual)
• Sponsor: Yooyoung Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 30 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

A multicenter, active-controlled, randomized, evaluator and subject blinded, split-face, comparative, non-inferiority, Medical device Clinical trial. This study is randomized, evaluator and subject blinded, split-face medical device Clinical trial. The Subjects are injected investigational device(YYD701-2 or Restylane Perlane Lidocaine) in right or left nasolabial folds.

Conditions

• Wrinkle Severity Rating Scale(WSRS) Grade 3 (Moderate) or 4 (Severe) of Nasolabial Folds

Interventions

Type	Name	Description
DEVICE	YYD701-2	HA Filler
DEVICE	Restylane Perlane Lidocaine	HA Filler

Timeline

• Start date: 2017-03-01
• Primary completion: 2017-11-21
• Completion: 2017-11-21
• First posted: 2017-05-30
• Last updated: 2021-05-10

Locations

2 sites across 1 country: South Korea